Get the Stockscreener App
44.88
3.60%
1.56
Supernus Pharmaceuticals Inc Stock (SUPN) Forecast
The Supernus Pharmaceuticals Inc (SUPN) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $17.85, representing a -60.22% decrease from the current price of $44.88. The highest analyst price target is $19.51, and the lowest is $16.20.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month SUPN Price Target
Average 18.89
(-57.90% Downside)
Is Supernus Pharmaceuticals Inc (SUPN) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 71.49 | Sell |
| STOCH(9,6) | 77.32 | Neutral |
| STOCHRSI(14) | 11.19 | Buy |
| MACD(12,26) | 2.4848 | Buy |
| ADX(14) | 58.29 | Buy |
| William %R | -11.85 | Sell |
| CCI(14) | 29.63 | Neutral |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
41.96
Buy
|
41.46
Buy
|
| MA20 |
38.71
Buy
|
39.47
Buy
|
| MA50 |
34.97
Buy
|
36.37
Buy
|
| MA100 |
33.50
Buy
|
34.87
Buy
|
| MA200 |
34.67
Buy
|
33.75
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, SUPN could be considered a Strong Buy, with 17 technical analysis indicators signaling 13 Buy signals, 2 signaling Sell signals and 2 Neutral signals. This might be a good time to open fresh positions on SUPN, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 71.49 indicates that SUPN is overbought. This suggests that SUPN price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
- STOCH (Stochastic Oscillator): The STOCH value of 77.32 indicates that SUPN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 11.19 indicates that SUPN is oversold. This suggests that SUPN price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 58.29 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 29.63 indicates that SUPN is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term SUPN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Supernus Pharmaceuticals Inc financial reports and earnings history, Supernus Pharmaceuticals Inc (SUPN) stock could reach $23.29 by 2030, $22.94 by 2040 and $4.4245 by 2050. See the projected annual prices until 2050 of the Supernus Pharmaceuticals Inc stock below:
- Supernus Pharmaceuticals Inc (SUPN) is expected to reach an average price of $17.32 in 2035, with a high prediction of $18.27 and a low estimate of $12.52. This indicates an $-61.41% rise from the last recorded price of $44.88.
- Supernus Pharmaceuticals Inc (SUPN) stock is projected to chart a bullish course in 2040, with an average price target of $20.72, representing an $-53.83% surge from its current level. The forecast ranges from a conservative $19.33 to a sky-high $22.94.
- Our analysts predict Supernus Pharmaceuticals Inc (SUPN) to jump -74.83% by 2045, soaring from $9.4311 to an average price of $11.30, potentially reaching $13.69. While $9.4311 is the low estimate, the potential upside is significant.
- Supernus Pharmaceuticals Inc (SUPN) stock is expected to climb by 2050, reaching an average of $3.1589, a $-92.96% jump from its current level. However, a wide range of estimates exists, with high and low targets of $4.4245 and $0.2574, respectively, highlighting the market's uncertainty.
Supernus Pharmaceuticals Inc Stock (SUPN) Year by Year Forecast
Supernus Pharmaceuticals Inc Stock (SUPN) Price Forecast for 2025
Supernus Pharmaceuticals Inc Stock (SUPN) is expected to reach an average price of $13.48 in 2025, with a high prediction of $19.87 and a low estimate of $7.0976. This indicates an -69.96% fall from the last recorded price of $44.88.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| September, 2025 | $17.12 | $16.20 | $19.51 | -61.85% |
| October, 2025 | $15.47 | $14.86 | $19.87 | -65.53% |
| November, 2025 | $14.91 | $14.04 | $16.82 | -66.77% |
| December, 2025 | $12.45 | $11.29 | $15.94 | -72.26% |
Supernus Pharmaceuticals Inc Stock (SUPN) Price Forecast for 2026
The predicted value for Supernus Pharmaceuticals Inc (SUPN) in 2026 is set at an average of $20.18. Estimates vary from a peak of $28.51 to a trough of $11.85, indicating an -55.04% surge from the present price of $44.88.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $15.98 | $11.85 | $19.30 | -64.40% |
| February, 2026 | $16.00 | $14.93 | $16.55 | -64.35% |
| March, 2026 | $23.36 | $15.32 | $23.94 | -47.96% |
| April, 2026 | $23.76 | $22.18 | $26.14 | -47.05% |
| May, 2026 | $20.31 | $17.34 | $25.84 | -54.75% |
| June, 2026 | $22.49 | $18.98 | $24.38 | -49.88% |
| July, 2026 | $24.74 | $21.78 | $26.50 | -44.87% |
| August, 2026 | $25.42 | $23.25 | $26.27 | -43.37% |
| September, 2026 | $22.64 | $22.28 | $28.51 | -49.55% |
| October, 2026 | $20.62 | $19.41 | $22.92 | -54.06% |
| November, 2026 | $21.79 | $17.40 | $21.90 | -51.44% |
| December, 2026 | $20.96 | $20.61 | $22.85 | -53.30% |
Supernus Pharmaceuticals Inc Stock (SUPN) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Supernus Pharmaceuticals Inc (SUPN) is $24.11, with a high forecast of $28.85 and a low forecast of $19.36. This indicates an -46.29% decrease from the last price of $44.88.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $24.12 | $20.42 | $26.61 | -46.25% |
| February, 2027 | $27.78 | $23.43 | $28.81 | -38.10% |
| March, 2027 | $23.02 | $21.46 | $28.49 | -48.71% |
| April, 2027 | $24.70 | $22.40 | $25.81 | -44.96% |
| May, 2027 | $25.29 | $22.28 | $26.57 | -43.66% |
| June, 2027 | $24.61 | $22.24 | $27.66 | -45.15% |
| July, 2027 | $26.71 | $23.98 | $27.48 | -40.49% |
| August, 2027 | $23.88 | $22.93 | $28.85 | -46.78% |
| September, 2027 | $22.82 | $19.36 | $24.80 | -49.15% |
| October, 2027 | $21.46 | $20.24 | $23.11 | -52.19% |
| November, 2027 | $24.60 | $21.15 | $25.15 | -45.19% |
| December, 2027 | $27.26 | $22.61 | $27.47 | -39.26% |
Supernus Pharmaceuticals Inc Stock (SUPN) Price Forecast for 2028
In 2028, Supernus Pharmaceuticals Inc (SUPN) is projected to reach an average price of $30.45, with a high projection of $36.66 and a low estimate of $24.24. This indicates an -32.15% fall from the last price of $44.88.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $28.87 | $26.57 | $30.56 | -35.67% |
| February, 2028 | $28.35 | $25.94 | $30.22 | -36.84% |
| March, 2028 | $28.79 | $24.51 | $29.44 | -35.86% |
| April, 2028 | $29.74 | $26.44 | $30.51 | -33.73% |
| May, 2028 | $32.02 | $29.33 | $32.95 | -28.66% |
| June, 2028 | $34.86 | $29.81 | $35.75 | -22.32% |
| July, 2028 | $33.25 | $31.93 | $36.66 | -25.92% |
| August, 2028 | $29.57 | $29.22 | $34.71 | -34.12% |
| September, 2028 | $31.70 | $28.93 | $31.76 | -29.37% |
| October, 2028 | $31.33 | $30.40 | $33.71 | -30.18% |
| November, 2028 | $28.17 | $27.22 | $32.70 | -37.23% |
| December, 2028 | $24.72 | $24.24 | $30.61 | -44.93% |
Supernus Pharmaceuticals Inc Stock (SUPN) Price Forecast for 2029
The 2029 price forecast for Supernus Pharmaceuticals Inc Stock (SUPN) is $23.49 on average, with a high prediction of $30.26 and a low estimate of $16.72. This represents an -47.67% decrease from the previous price of $44.88.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $25.37 | $23.72 | $25.89 | -43.48% |
| February, 2029 | $26.08 | $23.94 | $27.66 | -41.89% |
| March, 2029 | $23.93 | $23.43 | $27.51 | -46.67% |
| April, 2029 | $19.56 | $19.05 | $24.51 | -56.42% |
| May, 2029 | $21.39 | $16.72 | $21.73 | -52.35% |
| June, 2029 | $22.33 | $21.22 | $23.53 | -50.24% |
| July, 2029 | $23.71 | $20.89 | $24.67 | -47.18% |
| August, 2029 | $22.46 | $21.24 | $24.77 | -49.95% |
| September, 2029 | $23.86 | $21.57 | $23.99 | -46.84% |
| October, 2029 | $29.34 | $21.08 | $30.26 | -34.63% |
| November, 2029 | $24.23 | $23.46 | $29.80 | -46.01% |
| December, 2029 | $23.86 | $18.06 | $26.67 | -46.84% |
Supernus Pharmaceuticals Inc Stock (SUPN) Price Forecast for 2030
Supernus Pharmaceuticals Inc Stock (SUPN) is expected to reach an average price of $12.17 in 2030, with a high forecast of $23.29 and a low forecast of $1.0553. This signifies an -72.88% decrease from the last price of $44.88.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $19.13 | $17.25 | $23.29 | -57.37% |
| February, 2030 | $19.56 | $17.21 | $21.07 | -56.43% |
| March, 2030 | $20.10 | $18.95 | $21.67 | -55.20% |
| April, 2030 | $14.64 | $13.07 | $20.90 | -67.37% |
| May, 2030 | $15.19 | $14.09 | $17.46 | -66.16% |
| June, 2030 | $15.19 | $12.60 | $15.65 | -66.16% |
| July, 2030 | $9.5398 | $7.1203 | $17.13 | -78.74% |
| August, 2030 | $11.21 | $9.5465 | $11.35 | -75.01% |
| September, 2030 | $12.06 | $10.88 | $12.44 | -73.12% |
| October, 2030 | $11.90 | $10.59 | $13.02 | -73.49% |
| November, 2030 | $3.978 | $3.028 | $12.64 | -91.14% |
| December, 2030 | $5.042 | $1.0553 | $5.9752 | -88.77% |
2.37%
0.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):